Advancing Drug Safety in Drug Development: Bridging Computational Predictions for Enhanced Toxicity Prediction

Area of Science:

• Drug Development
• Computational Toxicology
• Pharmacology

Background:

• High attrition rates in drug development, around 90%, are often due to unexpected toxicity.
• Toxicity detected late in clinical trials or post-market significantly increases development costs.
• Understanding drug-biological target interactions is crucial for predicting efficacy and adverse effects.

Purpose of the Study:

• To review recent advancements in computational methods for predicting drug toxicity.
• To highlight the importance of drug-target binding affinity in anticipating adverse effects.
• To contribute to the development of safer and more effective drugs.

Main Methods:

• Review of computational approaches for evaluating protein-ligand interactions.
• Analysis of methods for predicting drug toxicity.
• Examination of the role of drug-target binding affinity in safety assessment.

Main Results:

• Computational methods offer a promising approach to predict drug toxicity, aligning with the 3Rs principles.
• Accurate prediction of drug-target interactions aids in evaluating compound safety and therapeutic effects.
• Focus on binding affinity can help anticipate and mitigate potential toxicities.

Conclusions:

• Computational toxicology is vital for improving the accuracy of drug safety assessments.
• Understanding drug-target interactions is key to reducing late-stage drug failures due to toxicity.
• Advancements in computational methods support the development of more effective and secure pharmaceuticals.